
Granules India Limited has informed the Exchange regarding a press release dated July 14, 2023, titled "Granules India Limited Announced Approval for the Store Brand OTC Equivalent of Advil�� Dual Action Tablets ".
Filed with NSE ·
Watch Granules India's latest callGranules India (NSE:GRANULES) Q2 2027 Earnings Call · Replay · Nov 2Read the transcript of Granules India (NSE:GRANULES) Q2 2027 Earnings Call
Granules India Limited has informed the Exchange regarding a press release dated July 14, 2023, titled "Granules India Limited Announced Approval for the Store Brand OTC Equivalent of Advil�� Dual Action Tablets ".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India